Learn all about PARP inhibitors with Dr Jon Krell, Consultant Medical Oncologist

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

PARP inhibitors and immunotherapy - Dr Yvette DrewПодробнее

Assessing the role of PARP inhibitors and immunotherapy in ovarian cancerПодробнее

PARP InhibitorsПодробнее

PARP Inhibitors simplifiedПодробнее

Precision Medicine in Ovarian Cancer With PARP Inhibitor Therapy and Companion DiagnosticsПодробнее

PARP inhibitors for ovarian cancerПодробнее

Webinar: PARP Inhibitors and Ovarian CancerПодробнее

Optimizing the Use of PARP Inhibitors in Ovarian CancerПодробнее

PARP Inhibitors For The Treatment & Prevention Of Hereditary Breast & Ovarian CancerПодробнее

Ovarian Cancer Symposium 2021: Session 4 PARP InhibitorsПодробнее

PARP Inhibitors: a Breakthrough in Cancer Therapy?Подробнее

Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer InstituteПодробнее

An Overview of PARP Inhibitors in Ovarian CancerПодробнее

Dr. Parsons Discusses the Role of PARP 7 in Overall Survival of Patients With Ovarian CancerПодробнее

PARP Inhibition in Recurrent Ovarian CancerПодробнее

Enhancing Personalized Medicine in Ovarian Cancer: Advances in PARP Inhibition and Novel ModalitiesПодробнее

PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian CancerПодробнее

The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP InhibitorsПодробнее